Journal
JOURNAL OF DRUG TARGETING
Volume 10, Issue 1, Pages 47-54Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1080/10611860290007522
Keywords
bacteria; cystic fibrosis; fusion; lipid-mixing assay; liposome
Categories
Ask authors/readers for more resources
Previous work demonstrated that fluid liposomes developed in our laboratory are able to fuse with bacterial outer membranes. This fusion improved the penetration and activity of liposome-encapsulated antibiotics and antisense oligonucleotides into the bacterial cells. Because it is anticipated that fluid liposome encapsulated antibiotics will be administered by aerosols to patients with chronic pulmonary infections or cystic fibrosis (CF), we conducted comparative studies in E. coli, P. aeruginosa and human lung epithelial cells using lipid-mixing assays to investigate the possibility that fluid liposomes might fuse with surrounding epithelial cells. After a 2 h incubation at 4 and 37degreesC, no fusion between fluid liposomes and human lung epithelial cells was observed, whereas mean levels of 71 and 37% of fusion were observed at 37degreesC with E. coli and P. aeruginosa cells, respectively. No fusion was observed at 4degreesC in any cells. A kinetic study where temperature was gradually increased from 7 to 37degreesC indicated that the fusion process in the two bacteria starts between 28 and 31degreesC with a mean fusion rate of 0.60%/min at 31degreesC to reach 1.18%/min at 37degreesC. The present work suggests that it is unlikely that fluid liposomes fuse with host cells lining the human respiratory tract and further elucidates the fusogenic properties of fluid liposomes with respect to prokaryotes and eukaryotes.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available